{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:27:38Z","timestamp":1786987658839,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.cyto.2011.11.006","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T12:14:51Z","timestamp":1323605691000},"page":"221-225","source":"Crossref","is-referenced-by-count":20,"title":["Serum levels of inflammation factors and cognitive performance in amnestic mild cognitive impairment: A Chinese clinical study"],"prefix":"10.1016","volume":"57","author":[{"given":"Sheng-Jie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ni","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2011.11.006_b0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2011.11.006_b0245","first-page":"95","article-title":"Clinical manifestations and diagnostic evaluation of patients with Alzheimer\u2019s disease","author":"Clark","year":"2000"},{"key":"10.1016\/j.cyto.2011.11.006_b0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer\u2019s disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cyto.2011.11.006_b0020","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.neurobiolaging.2008.02.007","article-title":"CSF biomarker levels in early and late onset Alzheimer\u2019s disease","volume":"30","author":"Bouwman","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cyto.2011.11.006_b0025","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1212\/01.WNL.0000123249.58898.E0","article-title":"Amyloid beta(1\u201342) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease","volume":"62","author":"Schoonenboom","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2011.11.006_b0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exger.2009.08.003","article-title":"Biomarkers of inflammation and amyloid-b phagocytosis in patients at risk of Alzheimer disease","volume":"45","author":"Fiala","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.cyto.2011.11.006_b0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/13554790490896820","article-title":"Stability and predictability of the classification of mild cognitive impairment as assessed by episodic memory test performance over time","volume":"11","author":"De Jager","year":"2005","journal-title":"Neurocase"},{"key":"10.1016\/j.cyto.2011.11.006_b0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JAD-2010-1219","article-title":"Neuroinflammation in Alzheimer\u2019s disease and mild cognitive impairment: a field in its infancy","volume":"19","author":"McGeer","year":"2010","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.cyto.2011.11.006_b0045","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jpsychires.2006.02.008","article-title":"Plasma cytokines profile in older subjects with late onset Alzheimer\u2019s disease or vascular dementia","volume":"41","author":"Zuliani","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.cyto.2011.11.006_b0050","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0197-4580(03)00010-1","article-title":"Peripheral cytokine release in Alzheimer patients: correlation with disease severity","volume":"24","author":"Sala","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cyto.2011.11.006_b0055","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00702-006-0575-6","article-title":"The significance of neuroinflammation in understanding Alzheimer\u2019s disease","volume":"111","author":"Eikelenboom","year":"2006","journal-title":"J Neural Trans"},{"key":"10.1016\/j.cyto.2011.11.006_b0060","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.neurobiolaging.2008.01.014","article-title":"Inflammatory markers in AD and MCI patients with different biomarker profiles","volume":"30","author":"Schuitemaker","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cyto.2011.11.006_b0065","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1523\/JNEUROSCI.23-07-02557.2003","article-title":"Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer\u2019s disease","volume":"23","author":"Yang","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.cyto.2011.11.006_b0070","doi-asserted-by":"crossref","unstructured":"Brian Giunta, Francisco Fernandez1, William V Nikolic, et a1. Inflammaging as a prodrome to Alzheimer\u2019s disease. J Neuroinflamm 2008;5:51.","DOI":"10.1186\/1742-2094-5-51"},{"key":"10.1016\/j.cyto.2011.11.006_b0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1037\/0894-4105.20.6.645","article-title":"The influence of APOE status on episodic and semantic memory: data from a population-based study","volume":"20","author":"Nilsson","year":"2006","journal-title":"Neuropsychology"},{"key":"10.1016\/j.cyto.2011.11.006_b0080","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archneur.59.7.1154","article-title":"The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period","volume":"59","author":"Wilson","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cyto.2011.11.006_b0085","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/418932a","article-title":"Cognitive change, the APOE epsilon 4 allele","volume":"418","author":"Deary","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2011.11.006_b0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cyto.2011.11.006_b0095","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neurobiolaging.2008.07.024","article-title":"Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer\u2019s disease in patients with mild cognitive impairment","volume":"31","author":"Kester","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cyto.2011.11.006_b0100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/nbdi.2002.0556","article-title":"Peripheral inflammatory response in Alzheimer\u2019s disease and multiinfarct dementia","volume":"11","author":"De Luigi","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.cyto.2011.11.006_b0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(99)00046-6","article-title":"Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer\u2019s disease (AD) individuals","volume":"97","author":"Lombardi","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2011.11.006_b0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-8-9","article-title":"APOE\u03b54 lowers age at onset, is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway","volume":"8","author":"Sando","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1016\/j.cyto.2011.11.006_b0250","first-page":"195","article-title":"Apolipoprotein E polymorphism and susceptibility to Alzheimer\u2019s disease","volume":"67","author":"Kambch","year":"1995","journal-title":"Hum Biol"},{"key":"10.1016\/j.cyto.2011.11.006_b0255","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000112109","article-title":"Reactive gliosis as a consequence of interleukin-6 expression in the brain, Studies in transgenic mice","volume":"16","author":"Chiang","year":"1994","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.cyto.2011.11.006_b0260","doi-asserted-by":"crossref","first-page":"9796","DOI":"10.1523\/JNEUROSCI.23-30-09796.2003","article-title":"Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase","volume":"23","author":"Sastre","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.cyto.2011.11.006_b0130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cyto.2011.11.006_b0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.CCM.0000186784.62662.A1","article-title":"Interleukin-6","volume":"33","author":"Song","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cyto.2011.11.006_b0140","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1523\/JNEUROSCI.5047-06.2007","article-title":"Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer\u2019s disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein","volume":"27","author":"Medeiros","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.cyto.2011.11.006_b0145","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1111\/j.1460-9568.2005.04457.x","article-title":"Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor","volume":"22","author":"Wang","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.cyto.2011.11.006_b0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0361-9230(03)00088-1","article-title":"Cerebral pattern of pro- and anti-inflammatory cytokines in dementias","volume":"61","author":"Tarkowski","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.cyto.2011.11.006_b0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.exger.2009.10.011","article-title":"Growth factors and cytokines\/chemokines as surrogate biomarkers in cerebrospinal fluid and blood for diagnosing Alzheimer\u2019s disease and mild cognitive impairment","volume":"45","author":"Olson","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.cyto.2011.11.006_b0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-5728(97)00021-0","article-title":"Apolipoprotein E suppresses glial cell secretion of TNF alpha","volume":"76","author":"Laskowitz","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2011.11.006_b0270","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mnfr.200700322","article-title":"Impact of apoE genotype on oxidative stress, inflammation and disease risk","volume":"52","author":"Jofre-Monseny","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.cyto.2011.11.006_b0170","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2005.12.012","article-title":"Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykja-vik study","volume":"186","author":"Eiriksdottir","year":"2006","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.cyto.2011.11.006_b0175","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.neurobiolaging.2008.01.014","article-title":"Inflammatory markers in AD and MCI patients with different biomarker profiles","volume":"30","author":"Schuitemaker","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cyto.2011.11.006_b0180","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.atherosclerosis.2005.12.012","article-title":"Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik study","volume":"186","author":"Eiriksdottir","year":"2006","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.cyto.2011.11.006_b0185","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2006.08.032","article-title":"Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease","volume":"48","author":"Tziakas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2011.11.006_b0190","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1010-7940(01)00842-9","article-title":"Genetic predisposition in patients undergoing cardiopulmonary bypass surgery is associated with an increase of inflammatory cytokines","volume":"20","author":"Drabe","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cyto.2011.11.006_b0195","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.imlet.2008.02.002","article-title":"Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer\u2019s disease","volume":"117","author":"Bermejoa","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.cyto.2011.11.006_b0200","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/gps.1816","article-title":"Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration","volume":"22","author":"Rozzini","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.cyto.2011.11.006_b0205","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jocn.2010.07.149","article-title":"A clinical memory battery for screening for amnestic mild cognitive impairment in an elderly Chinese population","volume":"18","author":"Zhao","year":"2011","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.cyto.2011.11.006_b0210","unstructured":"Walter Swardfager, Krista Lanct\u00f4t, Lana Rothenburg, et al. A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry 2010; Article in press. doi:10.1016\/j.biopsych. 2010.06.012."},{"key":"10.1016\/j.cyto.2011.11.006_b0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"1-2","key":"10.1016\/j.cyto.2011.11.006_b0275","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0165-5728(02)00398-3","article-title":"Inflammation markers in relation to cognition in a healthy aging population","volume":"134","author":"Teunissen","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2011.11.006_b0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0889-1591(02)00004-1","article-title":"Low levels of circulating inflammatory cytokines-do they affect human brain functions?","volume":"16","author":"Pollmacher","year":"2002","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.cyto.2011.11.006_b0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","article-title":"Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway","volume":"295","author":"Quintanilla","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cyto.2011.11.006_b0235","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1212\/01.WNL.0000073620.42047.D7","article-title":"Inflammatory markers and cognition in well-functioning African\u2013American and white elders","volume":"61","author":"Yaffe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2011.11.006_b0240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000052830","article-title":"Cytokine levels and phagocytic activity in patients with Alzheimer\u2019s disease","volume":"48","author":"Beloosesky","year":"2002","journal-title":"Gerontology"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611008167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466611008167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T15:08:02Z","timestamp":1561043282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466611008167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1043466611008167"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2011.11.006","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}